Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.
The chronic phase of HIV infection is marked by pathological activation of the immune system, the extent of which better predicts disease progression than either plasma viral load or CD4(+) T cell count. Recently, translocation of microbial products from the gastrointestinal tract has been proposed as an underlying cause of this immune activation, based on indirect evidence including the detection of microbial products and specific immune responses in the plasma of chronically HIV-infected humans or SIV-infected Asian macaques. We analyzed tissues from SIV-infected rhesus macaques (RMs) to provide direct in situ evidence for translocation of microbial constituents from the lumen of the intestine into the lamina propria and to draining and peripheral lymph nodes and liver, accompanied by local immune responses in affected tissues. In chronically SIV-infected RMs this translocation is associated with breakdown of the integrity of the epithelial barrier of the gastrointestinal (GI) tract and apparent inability of lamina propria macrophages to effectively phagocytose translocated microbial constituents. By contrast, in the chronic phase of SIV infection in sooty mangabeys, we found no evidence of epithelial barrier breakdown, no increased microbial translocation and no pathological immune activation. Because immune activation is characteristic of the chronic phase of progressive HIV/SIV infections, these findings suggest that increased microbial translocation from the GI tract, in excess of capacity to clear the translocated microbial constituents, helps drive pathological immune activation. Novel therapeutic approaches to inhibit microbial translocation and/or attenuate chronic immune activation in HIV-infected individuals may complement treatments aimed at direct suppression of viral replication.
Estes
Jacob D
JD
AIDS and Cancer Virus Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, USA. estesj@mail.nih.gov
Harris
Levelle D
LD
Klatt
Nichole R
NR
Tabb
Brian
B
Pittaluga
Stefania
S
Paiardini
Mirko
M
Barclay
G Robin
GR
Smedley
Jeremy
J
Pung
Rhonda
R
Oliveira
Kenneth M
KM
Hirsch
Vanessa M
VM
Silvestri
Guido
G
Douek
Daniel C
DC
Miller
Christopher J
CJ
Haase
Ashley T
AT
Lifson
Jeffrey
J
Brenchley
Jason M
JM
D000818:Animals; D016665:Cercocebus atys; D007413:Intestinal Mucosa / Q000473:pathology* / Q000821:virology*; D008253:Macaca mulatta; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology* / Q000473:pathology* / Q000821:virology*
Nat Med. 2006 Dec;12(12):1365-71
17115046
Nat Med. 2008 Oct;14(10):1077-87
18806803
J Immunol. 2008 May 15;180(10):6798-807
18453600
AIDS Clin Rev. 1997-1998;:187-228
9305449
J Clin Pathol. 1989 Mar;42(3):275-81
2703544
Hepatogastroenterology. 2007 Mar;54(74):342-5
17523270
Virology. 2003 Dec 5;317(1):119-27
14675630
AIDS. 2003 Sep 5;17(13):1881-8
12960820
Clin Exp Immunol. 2007 Dec;150(3):442-50
17956580
J Immunol. 2007 Feb 1;178(3):1680-91
17237418
Nat Med. 1999 Jan;5(1):83-9
9883844
PLoS Pathog. 2009 Feb;5(2):e1000295
19214220
J Immunol. 2004 Sep 1;173(5):3482-91
15322213
J Virol. 2006 May;80(10):4858-67
16641277
AIDS. 1996 Oct;10(12):1385-91
8902068
J Infect Dis. 2008 Feb 1;197(3):420-9
18199035
J Virol. 2005 Jul;79(14):9217-27
15994816
J Infect Dis. 2008 Aug 15;198(4):456-64
18598193
Gastroenterology. 2008 Jul;135(1):226-33
18457674
J Endotoxin Res. 2000;6(3):205-14
11052175
J Immunol. 2007 Sep 1;179(5):3026-34
17709517
Ann Surg. 2006 Mar;243(3):359-63
16495701
J Infect Dis. 2009 Apr 15;199(8):1177-85
19265479
J Clin Invest. 2001 Jun;107(12):1581-9
11413166
J Clin Virol. 2003 Feb;26(2):247-63
12600656
J Infect Dis. 1999 Apr;179(4):859-70
10068581
PLoS One. 2008 Jun 25;3(6):e2516
18575590
Transplantation. 2000 Jun 15;69(11):2415-21
10868651
Immunopharmacol Immunotoxicol. 2000 Aug;22(3):401-21
10946822
Immunity. 2003 Mar;18(3):441-52
12648460
Ann Intern Med. 1984 Oct;101(4):421-8
6476631
AIDS. 2007 Feb 19;21(4):433-9
17301561
Clin Sci (Lond). 1991 Sep;81(3):327-34
1655333
J Infect Dis. 1994 May;169(5):1116-20
8169404
J Virol. 2000 Feb;74(3):1209-23
10627531
Immunity. 2004 Oct;21(4):467-76
15485625
Blood. 2008 Oct 1;112(7):2826-35
18664624
J Clin Invest. 2002 Oct;110(8):1133-9
12393849
J Exp Med. 2006 Oct 2;203(10):2271-9
16982811
Bone Marrow Transplant. 1991 Nov;8(5):426-7
1768980
Antimicrob Agents Chemother. 2008 Sep;52(9):3377-84
18573939
J Clin Invest. 2005 Jan;115(1):66-75
15630445
Nat Immunol. 2006 Mar;7(3):235-9
16482171
Proc Natl Acad Sci U S A. 2005 Jul 12;102(28):9860-5
15980151
J Immunol. 2007 Sep 1;179(5):3035-46
17709518
N Engl J Med. 1984 Aug 23;311(8):536-7
6611503
Nat Med. 2006 Mar;12(3):289-95
16520776
J Med Primatol. 2005 Oct;34(5-6):303-12
16128925
J Virol. 2002 Dec;76(24):12448-56
12438570
Gut. 1999 Jul;45(1):70-6
10369707
Mucosal Immunol. 2008 Jul;1(4):279-88
19079189
Am J Surg Pathol. 2002 Jul;26(7):902-7
12131157
Annu Rev Immunol. 2001;19:423-74
11244043
Science. 1998 Apr 17;280(5362):427-31
9545219
AIDS. 2008 Oct 1;22(15):2035-8
18784466
Nature. 2005 Apr 28;434(7037):1148-52
15793562
Pancreas. 2003 Jan;26(1):18-22
12499912
J Endotoxin Res. 2002;8(6):441-8
12697087